Gene · 134
Papers2,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deconstructing aqueous humor outflow - The last 50 years. | Exp Eye Res | 2020 | 32590004 | PubTator, text mining | PubMed |
| Targeting Calcium Homeostasis in Myocardial Ischemia/Reperfusion Injury: An Overview of Regulatory Mechanisms and Therapeutic Reagents. | Front Pharmacol | 2020 | 32581817 | PubTator, text mining | PubMed |
| Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications. | Mol Imaging | 2020 | 32539522 | PubTator, text mining | PubMed |
| Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies. | Cancers (Basel) | 2020 | 32516941 | PubTator, text mining | PubMed |
| Evidence of a Recessively Inherited CCN3 Mutation as a Rare Cause of Early-Onset Parkinsonism. | Front Neurol | 2020 | 32499748 | PubTator, text mining | PubMed |
| Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4. | Mol Pharmacol | 2020 | 32474443 | PubTator, text mining | PubMed |
| HIV Tat Protein Selectively Impairs CB1 Receptor-Mediated Presynaptic Inhibition at Excitatory But Not Inhibitory Synapses. | eNeuro | 2020 | 32471847 | PubTator, text mining | PubMed |
| An Analysis of the Anti-Neuropathic Effects of Qi She Pill Based on Network Pharmacology. | Evid Based Complement Alternat Med | 2020 | 32454869 | PubTator, text mining | PubMed |
| Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs. | Comput Struct Biotechnol J | 2020 | 32419905 | PubTator, text mining | PubMed |
| IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway. | Cancer Lett | 2020 | 32417395 | PubTator, text mining | PubMed |
| Metformin: A Possible Option in Cancer Chemotherapy. | Anal Cell Pathol (Amst) | 2020 | 32399389 | PubTator, text mining | PubMed |
| Genomics of Blood Pressure and Hypertension: Extending the Mosaic Theory Toward Stratification. | Can J Cardiol | 2020 | 32389342 | PubTator, text mining | PubMed |
| Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs. | Antiviral Res | 2020 | 32387475 | PubTator, text mining | PubMed |
| Bisphenolic compounds alter gene expression in MCF-7 cells through interaction with estrogen receptor α. | Toxicol Appl Pharmacol | 2020 | 32387340 | PubTator, text mining | PubMed |
| Adenosine and the Cardiovascular System: The Good and the Bad. | J Clin Med | 2020 | 32384746 | PubTator, text mining | PubMed |
| Exploring Molecular Mechanism of Huangqi in Treating Heart Failure Using Network Pharmacology. | Evid Based Complement Alternat Med | 2020 | 32382301 | PubTator, text mining | PubMed |
| Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges. | Gut | 2020 | 32381514 | PubTator, text mining | PubMed |
| Anti-Tumor Activity vs. Normal Cell Toxicity: Therapeutic Potential of the Bromotyrosines Aerothionin and Homoaerothionin In Vitro. | Mar Drugs | 2020 | 32369901 | PubTator, text mining | PubMed |
| Single Nucleotide and Copy-Number Variants in IL4 and IL13 Are Not Associated with Asthma Susceptibility or Inflammatory Markers: A Case-Control Study in a Mexican-Mestizo Population. | Diagnostics (Basel) | 2020 | 32366038 | PubTator, text mining | PubMed |
| Penalized logistic regression based on L1/2 penalty for high-dimensional DNA methylation data. | Technol Health Care | 2020 | 32364148 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134/papers?page=38